Essex Bio-Technology Gestion
Gestion contrôle des critères 4/4
Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.
Informations clés
Haizhou Fang
Directeur général
HK$1.7m
Rémunération totale
| Pourcentage du salaire du PDG | 97.5% |
| Durée du mandat du directeur général | no data |
| Propriété du PDG | 0.9% |
| Durée moyenne d'occupation des postes de direction | 23.8yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 4.2yrs |
Mises à jour récentes de la gestion
Recent updates
Essex Bio-Technology Limited (HKG:1061) Surges 29% Yet Its Low P/E Is No Reason For Excitement
Oct 09
Essex Bio-Technology's (HKG:1061) Upcoming Dividend Will Be Larger Than Last Year's
Aug 29Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement
May 06Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)
Mar 21Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet
Dec 07Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly
Dec 07Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04
Aug 25Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?
Jun 22Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055
May 02Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055
Mar 30Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly
Jun 29Is Essex Bio-Technology (HKG:1061) A Risky Investment?
Mar 31If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today
Mar 13How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?
Feb 15
Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?
Jan 25Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Jan 04Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly
Dec 13Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters
Nov 23Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | HK$263m |
| Mar 31 2024 | n/a | n/a | HK$269m |
| Dec 31 2023 | HK$2m | HK$2m | HK$275m |
| Sep 30 2023 | n/a | n/a | HK$266m |
| Jun 30 2023 | n/a | n/a | HK$256m |
| Mar 31 2023 | n/a | n/a | HK$241m |
| Dec 31 2022 | HK$2m | HK$2m | HK$225m |
| Sep 30 2022 | n/a | n/a | HK$274m |
| Jun 30 2022 | n/a | n/a | HK$323m |
| Mar 31 2022 | n/a | n/a | HK$334m |
| Dec 31 2021 | HK$2m | HK$2m | HK$346m |
| Sep 30 2021 | n/a | n/a | HK$339m |
| Jun 30 2021 | n/a | n/a | HK$332m |
| Mar 31 2021 | n/a | n/a | HK$275m |
| Dec 31 2020 | HK$2m | HK$2m | HK$219m |
| Sep 30 2020 | n/a | n/a | HK$221m |
| Jun 30 2020 | n/a | n/a | HK$222m |
| Mar 31 2020 | n/a | n/a | HK$262m |
| Dec 31 2019 | HK$2m | HK$737k | HK$303m |
| Sep 30 2019 | n/a | n/a | HK$282m |
| Jun 30 2019 | n/a | n/a | HK$262m |
| Mar 31 2019 | n/a | n/a | HK$246m |
| Dec 31 2018 | HK$2m | HK$766k | HK$231m |
| Sep 30 2018 | n/a | n/a | HK$210m |
| Jun 30 2018 | n/a | n/a | HK$189m |
| Mar 31 2018 | n/a | n/a | HK$178m |
| Dec 31 2017 | HK$2m | HK$721k | HK$167m |
Rémunération vs marché: La rémunération totale de Haizhou ($USD 224.31K ) est inférieure à la moyenne des entreprises de taille similaire sur le marché Hong Kong ($USD 359.96K ).
Rémunération et revenus: La rémunération de Haizhou a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Haizhou Fang (58 yo)
no data
Titularisation
HK$1,744,587
Compensation
Mr. Haizhou Fang serves as the Managing Director and Executive Director of Essex Bio-Technology Limited and served as its General Manager. Mr. Fang is qualified as a Senior Pharmaceutical Engineer (Profess...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Founder & Chairman | no data | HK$3.23m | 52.75% HK$ 805.1m | |
| MD & Executive Director | no data | HK$1.74m | 0.92% HK$ 14.1m | |
| Executive Director & Deputy MD | no data | HK$1.80m | 0.36% HK$ 5.5m | |
| Executive Director & Company Secretary | 23.8yrs | HK$755.60k | 0.0081% HK$ 123.8k | |
| Group Chief Scientific Officer | 6.6yrs | pas de données | pas de données |
23.8yrs
Durée moyenne de l'emploi
60yo
Âge moyen
Gestion expérimentée: L'équipe dirigeante de 1061 est chevronnée et expérimentée (23.8 années d'ancienneté moyenne).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Founder & Chairman | no data | HK$3.23m | 52.75% HK$ 805.1m | |
| MD & Executive Director | no data | HK$1.74m | 0.92% HK$ 14.1m | |
| Executive Director & Deputy MD | 4.2yrs | HK$1.80m | 0.36% HK$ 5.5m | |
| Executive Director & Company Secretary | 4.2yrs | HK$755.60k | 0.0081% HK$ 123.8k | |
| Independent Non Executive Director | 23.4yrs | HK$250.00k | pas de données | |
| Independent Non Executive Director | 20.2yrs | HK$220.00k | pas de données | |
| Independent Non-Executive Director | 1.4yrs | HK$128.33k | pas de données |
4.2yrs
Durée moyenne de l'emploi
61yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de 1061 sont considérés comme expérimentés (ancienneté moyenne 4.2 ans).